IP

IP

ANI v. OpenAI in the Delhi HC: Everything so far and all that is at stake
ANI versus OpenAI: Is ‘open-source’, large language model AI above intellectual property norms?
David defeats Goliath: Pune court ruling against US ‘Burger King’ in favour of local competitor
Art, artificial intelligence and the law
Is India’s legal framework ready to deal with sexual violence in virtual reality?
India’s quest for a workable AI legislation
Policing the internet: Kerala’s increasing crackdown on free speech online
Representative Image Only
Representative Image Only
Representative Image Only
Representative Image Only
150 years of Gauhar Jaan: Celebrating a star performer light years ahead of her time
Representative Image Only
The need for access to anti-TB drugs in India: An interview with Anand Grover
Representative Image Only
Representative Image Only
Panel discussion on Intellectual Property and the Constitution: accessibility, vaccine waivers and content creation
Leaked Text Incorporates Stringent TRIPS Plus Elements, Global Calls for Rejection Increase
Leaked WTO Draft Text on TRIPS Waiver Reveals ‘Compromise’
SC expresses concern over frivolous appeals clogging the system
HC orders blocking of rogue websites illegally telecasting cricket matches
CJI rues lack of basic judicial infrastructure
Representative Image Only | Courtesy: IP Law Portal
COVID-19 and the Shortage of Drugs: A Case for Compulsory Licensing
Representative Image.
Representative Image.
Covid-19 Pandemic Calls for Early Relaxations on IPRs
Covid19: Why aren’t you buying all doses; when will you disburse 50% of doses to states; what is the rationale for differential pricing: SC to Centre
Representative Image. Photo Credit: The Indian Express.
Bombay HC directs Centre to decide representation seeking ‘compulsory licenses’ to two patented anti-TB drugs
Read More
The Leaflet
theleaflet.in